๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised e vidence


Book ID
117311752
Publisher
The Lancet
Year
1999
Tongue
English
Weight
199 KB
Volume
353
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Intermittent selection pressure with zid
โœ Izopet, J.; Sailler, L.; Sandres, K.; Pasquier, C.; Bonnet, E.; Aquilina, C.; Pu ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 112 KB ๐Ÿ‘ 1 views

The development of mutations conferring drug resistance was investigated in 49 antiretroviralnaive asymptomatic HIV-1 subjects with CD4 + cell counts of 250-500/mm 3 given intermittent (6-week courses, 6 weeks apart) or continuous treatment with zidovudine (AZT) plus zalcitabine (ddC) over 54 weeks.